Latest Capital Raising News

Qualitas Limited posted a 25% rise in net profit for FY26, driven by a 36% increase in fee earning funds under management and a strategic UK acquisition that expands its European presence.

Prodigy Gold NL is transitioning from exploration to development, underpinned by a robust scoping study at Hyperion and progressing approvals to restart mining at Twin Bonanza's Old Pirate mine.

InVert Graphite has secured full ownership of RapidGraphite, gaining exclusive rights to RapidPulse technology that promises to transform graphite processing with a rapid, sustainable method. The company raised A$2.5 million to fund scaled-up trials, aiming to integrate this breakthrough with its Tanzanian graphite assets.

Wrkr Ltd surged revenue 52.6% to $16.2 million in FY2026 but saw net losses widen to $8.4 million as it transitioned to live Payday Super execution and integrated PaidRight. The company raised $12 million post-year-end to fuel onboarding and product growth.

Cleo Diagnostics (ASX:COV) posted a 48% jump in annual loss to $5.9 million amid key progress in its ovarian cancer diagnostic test, including completion of a pivotal US trial and preparations for FDA 510(k) submission.

At its 2026 Annual Meeting, General Capital shareholders voted decisively against re-electing Managing Director Brent King, while approving a near 10% increase in the total director remuneration pool.

WhiteRock Lithium Corp. reported a CAD 5.96 million net loss for 2025, deepening its accumulated deficit amid dwindling cash reserves and a material going concern warning from auditors. The company disposed of its Chavamond property and extended warrant expiry dates in a bid to manage liquidity and capital structure.

Medallion Metals has raised A$60 million through a targeted placement, boosting its liquidity to about A$175 million and enabling accelerated development of its Ravensthorpe Gold Project and drilling programs in Western Australia.

Whitefield Income Ltd (ASX: WHI) posted a 10.1% gross income yield for FY26 and completed a heavily oversubscribed $108 million capital raise, boosting its market cap to $400 million. The company announced fully franked dividends and highlighted a positive outlook despite geopolitical risks.

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.

Dart Mining (ASX:DTM) has agreed to acquire a large, underexplored gold and lithium project near the Gruyere mine in WA’s Yamarna district, backed by a $2 million capital raise to fund exploration and acquisition costs.

Viridis Mining and Minerals completes a Definitive Feasibility Study for its Colossus Rare Earth Project, confirming strong economics and project readiness, while securing $120 million in equity funding to advance into execution.